Internal Medicine Doctors in Whitehouse Station, NJ Accepting Medicare
6 Internal Medicine doctors found. Showing 1 - 6
 Dr. Christina Yu-yee Chan, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1 Merck Dr, Ws 2d-19, Whitehouse Station, NJ 08889 Phone: 908-423-6048 |
Mitra Abessi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 537 Us Highway 22 E Fl 3, Whitehouse Station, NJ 08889 Phone: 908-237-4155 Fax: 908-534-6634 |
 Dr. Robert Falcone, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Merck Dr, Ws 1af-35, Whitehouse Station, NJ 08889 Phone: 908-423-4115 Fax: 908-534-3234 |
Sumit Agarwal, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 537 Us Highway 22 E Fl 3, Whitehouse Station, NJ 08889 Phone: 908-237-4155 Fax: 908-534-6634 |
Dr. Robert James Cody, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Merck Dr, Whitehouse Station, NJ 08889 Phone: 908-391-8284 |
Dr. Stephen Ocken, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 115 Van Cleef Dr, Whitehouse Station, NJ 08889 Phone: 908-400-9805 Fax: 908-923-4092 |
News Archive
Washington State cracks down on prescription fraud with new paper and ink
The Seattle Post Intelligencer/Everett Herald: "Patients who get written prescriptions will see changes this summer aimed at curbing fraud. Come July 1, prescriptions will be printed on tamper-resistant paper with Mission Impossible-like ink that changes color when rubbed with a finger.
UF Health investigators make new discovery about Huntington's disease
University of Florida Health researchers have made a new discovery about Huntington's disease, showing that the gene that causes the fatal disorder makes an unexpected "cocktail" of mutant proteins that accumulate in the brain.
FDA grants Orphan Drug Designation to CD4CAR therapy for treatment of peripheral T-cell lymphoma
iCell Gene Therapeutics today (Aug. 11) announced that the Food and Drug Administration has granted Orphan Drug Designation for its chimeric antigen receptor engineered T-cells directed against the target protein CD4 (CD4CAR) for the treatment of peripheral T-cell lymphoma (PTCL).
Rheumatoid arthritis risk reduced by moderate alcohol consumption
Moderate consumption of alcohol is associated with a reduced risk of developing rheumatoid arthritis, suggests a study published on bmj.com today.
› Verified 7 days ago
Internal Medicine
Family Medicine
Cardiovascular Disease
Psychiatry & Neurology
Pediatrics
Emergency Medicine
Infectious Disease